期刊
JOURNAL OF INTERNAL MEDICINE
卷 285, 期 1, 页码 19-39出版社
WILEY
DOI: 10.1111/joim.12820
关键词
Biosensors; Diagnostics; Digital pathology; Lab-on-a-chip; Smartphones
资金
- Kenan Institute for Engineering, Technology & Science (KIETS)
- European Union's Horizon 2020 research and innovation programme 'New Diagnostics for Infectious Diseases' (ND4ID) [675412]
- SSF project FLU-ID
- Swedish Research Council
- Swedish Cancer Foundation [2015/838]
- SciLifeLab
Recent advancements in bioanalytical techniques have led to the development of novel and robust diagnostic approaches that hold promise for providing optimal patient treatment, guiding prevention programs and widening the scope of personalized medicine. However, these advanced diagnostic techniques are still complex, expensive and limited to centralized healthcare facilities or research laboratories. This significantly hinders the use of evidence-based diagnostics for resource-limited settings and the primary care, thus creating a gap between healthcare providers and patients, leaving these populations without access to precision and quality medicine. Smartphone-based imaging and sensing platforms are emerging as promising alternatives for bridging this gap and decentralizing diagnostic tests offering practical features such as portability, cost-effectiveness and connectivity. Moreover, towards simplifying and automating bioanalytical techniques, biosensors and lab-on-a-chip technologies have become essential to interface and integrate these assays, bringing together the high precision and sensitivity of diagnostic techniques with the connectivity and computational power of smartphones. Here, we provide an overview of the emerging field of clinical smartphone diagnostics and its contributing technologies, as well as their wide range of areas of application, which span from haematology to digital pathology and rapid infectious disease diagnostics.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据